In addition, the prognostic signature-based risk score built according to the expression levels of KIAA1429, RBM15, and HNRNPC, was not only strongly associated with clinical outcomes and clinicopathological features, but also an independent prognostic factor in lung adenocarcinoma. Here, HNRNPC is linked to lung adenocarcinoma.